BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30687765)

  • 1. Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated
    Chetchotisakd P; Anunnatsiri S; Nanagara R; Nithichanon A; Lertmemongkolchai G
    J Immunol Res; 2018; 2018():6473629. PubMed ID: 30687765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.
    Hong GH; Ortega-Villa AM; Hunsberger S; Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Rosen LB; Zerbe CS; Holland SM
    Clin Infect Dis; 2020 Jun; 71(1):53-62. PubMed ID: 31429907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
    Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
    BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
    Rujirachun P; Sangwongwanich J; Chayakulkeeree M
    BMC Infect Dis; 2020 Mar; 20(1):232. PubMed ID: 32188404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome.
    Angkasekwinai N; Suputtamongkol Y; Tantibhedhyangkul W; Onlamoon N; Phoompoung P; Pithukpakorn M; Karuphong E; Pusuwan P; Angkasekwinai P
    Clin Infect Dis; 2024 Apr; 78(4):1033-1042. PubMed ID: 37947190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated nontuberculous mycobacterial infection with cryptic immunodeficiency mimicking malignancy: a case report.
    Sun X; Zhang T; Sun H; Sun X
    BMC Pulm Med; 2022 Nov; 22(1):452. PubMed ID: 36447235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
    Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
    PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
    Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
    J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
    Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
    PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
    Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
    Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients.
    Chetchotisakd P; Anunnatsiri S
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1125-31. PubMed ID: 25417515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
    Yeh YK; Ding JY; Ku CL; Chen WC
    BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple refractory intracellular pathogen infections in a human immunodeficiency virus-negative patient with anti-interferon-γ autoantibodies: a case report.
    Wang H; Lei R; Ji Y; Xu W; Zhang K; Guo X
    BMC Infect Dis; 2023 Jul; 23(1):493. PubMed ID: 37495965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
    Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
    Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
    Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
    BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection by
    Jin W; Liu J; Chen K; Shen L; Zhou Y; Wang L
    J Int Med Res; 2021 Jan; 49(1):300060520976471. PubMed ID: 33435770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.